National THA endorsement leads to criticism from its members. read blog
With more stability in racing dates in the Mid-Atlantic region, the chairman of the THA plans to hold a fact-finding meeting to see if there is interest in bringing back the MATCH series.
An initial introduction in Kentucky of the Mid-Atlantic Uniform Medication Program received raised eyebrows, but supporters of the changes are encouraged that the important racing state is giving the program consideration.
- By Tom LaMarra
A horsemen's group official involved in development of the proposed model rule for multiple violation penalties said July 15 the regulations are a "living document" that probably will be adjusted based on industry needs.
The Thoroughbred Owners of California will join regulators from eight states in the Mid-Atlantic and Northeast by committing to implement the Mid-Atlantic Uniform Medication Program in January 2014.
Racing Commissioners International gave final approval April 2 to the "RCI Controlled Therapeutic Medication Schedule," setting the stage for uniform implementation of racing medication rules in the U.S.
The regulators of eight states in the Northeast region have committed to a uniform medication and drug testing program in a move supporters believe is a step toward uniform regulation of medication and drug testing.
The Pennsylvania Thoroughbred Horsemen's Association, which represents horsemen at Parx Racing, is back under the umbrella of the Thoroughbred Horsemen's Association, the parties said Dec. 14.
- By Tom LaMarra
The largest horsemen's groups in the country said they don't support a call by the Association of Racing Commissioners International for a five-year phase-out of race-day anti-bleeding medications.
Though questions persist about TrackNet Media Group, the entity formed by Churchill Downs Inc. and Magna Entertainment Corp. to buy and sell simulcast signals, it has generated an initial positive response from one of the country's major horsemen's groups.
The Board of Directors of the Racing Medication and Testing Consortium approved a plan developed by Dr. Rick Sams of The Ohio State University to establish guidelines for withdrawal times for therapeutic medications utilized by racetrack veterinarians.
Mid-Atlantic regulators and the Thoroughbred Horsemen's Association are scheduled to meet June 12 in New Jersey to discuss medication and drug-testing issues on a regional and national scope.
Setting a national policy for racehorse medication is a vital step for the sport's long-term health, a top industry executive told the 2002 Harness Racing Congress in Las Vegas, Nev., Feb. 20.
California is on board with a nationwide push for a consensus on racehorse medication, the president of the Thoroughbred Owners of California reported to his board the week of Dec. 10. But the TOC does have its own opinions on some of the specifics.
The Thoroughbred Horsemen's Association on Nov. 27 issued a list of recommendations that call for a restructuring of medication use and drug testing procedures in horse racing. Among them are formation of a non-profit consortium that would be funded via a per-start fee for every Thoroughbred, Standardbred, and Quarter Horse.
The Thoroughbred Horsemen's Association hopes to release a sweeping national medication and drug-testing proposal either before or during the University of Arizona Symposium on Racing, which begins Dec. 4. It would become the second major horsemen's group to issue a medication proposal this fall.
Most Popular Stories
- BC Classic Winner Concern Dies at 25
- Unlocking Winners: Dubai and the Derby Preps
- Champion Sire Smart Strike Euthanized
- Wise Dan Making Progress, Still Tack-Walking
- Shared Belief Traveling East for CT Classic
- VLT Expansion Proposals Shot Down in New York
- MA House Passes Suffolk Simulcast Extension
- Commissioner Eyes Easier Skip Away Prize
- RMTC Board Announces Cobalt Threshold
- That Handicapping Show: Louisiana Derby